2Seventy Total Stockholder Equity from 2010 to 2024
| TSVT Stock | USD 4.80 0.20 4.00% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 255.3 M | Current Value 229.7 M | Quarterly Volatility 114.4 M |
Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 10.8 M or Depreciation And Amortization of 13.1 M, as well as many exotic indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 0.78. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
2Seventy | Total Stockholder Equity |
Latest 2Seventy Bio's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of 2Seventy Bio over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. 2Seventy Bio's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 2Seventy Bio's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
2Seventy Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 111,119,799 | |
| Geometric Mean | 74,623,850 | |
| Coefficient Of Variation | 102.95 | |
| Mean Deviation | 94,769,171 | |
| Median | 43,692,000 | |
| Standard Deviation | 114,401,566 | |
| Sample Variance | 13087.7T | |
| Range | 316.1M | |
| R-Value | 0.73 | |
| Mean Square Error | 6485.9T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 18,795,089 | |
| Total Sum of Squares | 183228.1T |
2Seventy Total Stockholder Equity History
About 2Seventy Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include 2Seventy Bio income statement, its balance sheet, and the statement of cash flows. 2Seventy Bio investors use historical funamental indicators, such as 2Seventy Bio's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may use each financial statement separately, they are all related. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on 2Seventy Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on 2Seventy Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in 2Seventy Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 255.3 M | 229.7 M |
Pair Trading with 2Seventy Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 2Seventy Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2Seventy Bio will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to 2Seventy Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 2Seventy Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 2Seventy Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 2Seventy Bio to buy it.
The correlation of 2Seventy Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 2Seventy Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 2Seventy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 2Seventy Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of 2Seventy Bio Correlation against competitors. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for 2Seventy Stock analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.35) | Revenue Per Share 1.385 | Quarterly Revenue Growth (0.70) | Return On Assets (0.21) | Return On Equity (0.73) |
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.